ISDB Newsletter July 2024

A new ISDB Newsletter issue has just been released. Please, enjoy reading at: https://isdbweb.org/publication/newsletter/isdb-newsletter-july-2024

ISDB response to the public consultation on the transparency rules for the operation of the Clinical Trials Regulation (CTR) and its Clinical Trials Information System (CTIS)

The ISDB has recently responded to a public consultation from EMA, the Heads of Medicines Agencies and the European Commission on the Clinical Trials Regulation and its information system. You can consult the whole content of this statement at: https://isdbweb.org/publication/documents-of-interest/isdb-response-to-the-public-consultation-on-the-clinical-trials-regulation-and-its-information-system

Access to regulatory documents

Dr. Juan Erviti, former DTB Navarre coordinator and ISDB secretary, has recently presented a webinar at Therapeutics Initiative on “The need for access to regulatory documents for better drug assessment“. The video is freely available at https://www.youtube.com/watch?v=LTk4bbQnBX0

ISDB Strategic Plan

As part of a strategic plan for ISDB, the executive committee has launched two subgroups to reflect ISDB’s membership and on its mission and activities. On-line meetings have been taken place during 2023/2024. The groups are expected to make recommendations very soon. Stay tuned!

______________________________________________________________________________________________